SCHEMBL11005661

SCHEMBL11005661

Cc1nc[nH]c1CSCCNC(=NC#N)NCCSCc1[nH]cnc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.51
▸ CYP2D6 P10635 3/20 0.51
▸ HRH2 P25021 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ TSHR P16473 2/20 0.51
▸ SLC47A1 Q96FL8 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ SLC22A2 O15244 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ GLA P06280 1/20 0.51
▸ ATP4A P20648 1/20 0.51
▸ APEX1 P27695 1/20 0.51
▸ PDE4A P27815 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ ADRA1A P35348 1/20 0.51
▸ ATP4B P51164 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ SLC47A2 Q86VL8 1/20 0.51
▸ SLC22A8 Q8TCC7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cimetidine SCHEMBL15316685 0.94 HRH2 (0.48) CYP3A4CYP2D6HRH2LMNATSHR
Cimetidine SCHEMBL11283011 0.94 HRH2 (0.48) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL11081872 0.91 HRH2 (0.44) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL11006349 0.87 HRH2 (0.43) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL11183005 0.86 HRH2 (0.43) CYP3A4CYP2D6HRH2LMNATSHR
Cimetidine SCHEMBL7355222 0.84 CYP3A4 (0.72) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL11173932 0.84 HRH2 (0.41) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL11075509 0.82 HRH2 (0.57) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL11001853 0.82 HRH2 (0.57) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL11084201 0.82 HRH2 (0.57) CYP3A4CYP2D6HRH2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4152443-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-05-01 — — US claimed
US-4499101-A HISTAMINE H2-ANTAGONISTS; ANTISECRETORY ANTIINFLAMMOATORY AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-02-12 — — US disclosed
US-4499101-A HISTAMINE H2-ANTAGONISTS; ANTISECRETORY ANTIINFLAMMOATORY AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-02-12 — — US disclosed
US-4388319-A ANTIHISTAMINES, ANTISECRETORY, ANTIINFLAMMATORY, HYPOTENSIVE AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1983-06-14 — — US disclosed
US-4271169-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-06-02 — — US disclosed
US-4215125-A H-2 HISTAMINE RECEPTOR INHIBITORS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-07-29 — — US disclosed
US-4152443-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-05-01 — — US disclosed
US-4152443-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-05-01 — — US disclosed
US-4112104-A UREA, THIOUREA OR GUANIDINE DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-09-05 — — US disclosed
US-4025527-A H-2 HISTAMINE RECEPTOR INHIBITORS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-24 — — US disclosed
US-4025527-A H-2 HISTAMINE RECEPTOR INHIBITORS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-24 — — US disclosed
Send feedback